CEFTAROLINE FOSAMIL

CEFTAROLINE FOSAMIL was reported 839 times

These side effects are most commonly reported by patients taking CEFTAROLINE FOSAMIL:

# Side effect Count
0 OFF LABEL USE 141
1 NEUTROPENIA 77
2 DRUG INEFFECTIVE 64
3 ACUTE KIDNEY INJURY 52
4 DEATH 48
5 RASH 46
6 AGRANULOCYTOSIS 40
7 THROMBOCYTOPENIA 37
8 PYREXIA 34
9 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 33
10 RENAL FAILURE 31
11 PRURITUS 29
12 TOXIC EPIDERMAL NECROLYSIS 27
13 EOSINOPHILIA 26
14 STAPHYLOCOCCAL INFECTION 24
15 LEUKOPENIA 23
16 TREATMENT FAILURE 23
17 GENERAL PHYSICAL HEALTH DETERIORATION 22
18 ANAEMIA 21
19 PANCYTOPENIA 20
20 NAUSEA 19
21 PRODUCT STORAGE ERROR 19
22 HYPERTRANSAMINASAEMIA 16
23 HYPOTENSION 16
24 RASH MACULO-PAPULAR 16
25 COVID-19 15
26 OEDEMA 15
27 VOMITING 15
28 DIARRHOEA 14
29 DRUG INTERACTION 14
30 TRANSAMINASES INCREASED 14
31 DYSPNOEA 13
32 ENCEPHALOPATHY 13
33 PSEUDOMONAS INFECTION 13
34 SKIN ULCER 13
35 STEVENS-JOHNSON SYNDROME 13
36 ASCITES 12
37 CHILLS 12
38 CYTOMEGALOVIRUS INFECTION 12
39 FLUID INTAKE REDUCED 12
40 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 12
41 CONDITION AGGRAVATED 11
42 PRODUCT USE IN UNAPPROVED INDICATION 11
43 BLOOD CREATININE INCREASED 10
44 DISEASE PROGRESSION 10
45 FATIGUE 10
46 HEPATOTOXICITY 10
47 RESPIRATORY FAILURE 10
48 STAPHYLOCOCCAL BACTERAEMIA 10
49 DRUG HYPERSENSITIVITY 9
50 HYPOPHAGIA 9
51 INTERNATIONAL NORMALISED RATIO INCREASED 9
52 PRODUCT USE ISSUE 9
53 RASH ERYTHEMATOUS 9
54 SEPTIC SHOCK 9
55 WHITE BLOOD CELL COUNT DECREASED 9
56 BACTERAEMIA 8
57 CONFUSIONAL STATE 8
58 FALL 8
59 HYPOKALAEMIA 8
60 PATHOGEN RESISTANCE 8
61 RENAL IMPAIRMENT 8
62 TUBULOINTERSTITIAL NEPHRITIS 8
63 ASTHENIA 7
64 CUTANEOUS VASCULITIS 7
65 EOSINOPHILIC PNEUMONIA 7
66 HAEMARTHROSIS 7
67 HAEMOGLOBIN DECREASED 7
68 HEPATIC FAILURE 7
69 OEDEMA PERIPHERAL 7
70 PAIN 7
71 SEPSIS 7
72 ABDOMINAL PAIN 6
73 ALANINE AMINOTRANSFERASE INCREASED 6
74 BACK PAIN 6
75 DIZZINESS 6
76 ERYTHEMA 6
77 FEBRILE NEUTROPENIA 6
78 HAEMOLYSIS 6
79 HEADACHE 6
80 HEPATIC CYTOLYSIS 6
81 HYPERSENSITIVITY 6
82 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6
83 PNEUMONIA 6
84 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6
85 ANAPHYLACTIC REACTION 5
86 ASPARTATE AMINOTRANSFERASE INCREASED 5
87 CANDIDA INFECTION 5
88 CHEST PAIN 5
89 COUGH 5
90 DEPRESSED LEVEL OF CONSCIOUSNESS 5
91 DRUG RESISTANCE 5
92 EOSINOPHIL COUNT INCREASED 5
93 HAEMOLYTIC ANAEMIA 5
94 HYPERKALAEMIA 5
95 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5
96 INCORRECT PRODUCT ADMINISTRATION DURATION 5
97 MALAISE 5
98 MEDICATION ERROR 5
99 OSTEOMYELITIS 5
100 RASH PRURITIC 5
101 TREMOR 5
102 URTICARIA 5
103 ABDOMINAL DISCOMFORT 4
104 BLOOD CREATINE PHOSPHOKINASE INCREASED 4
105 BLOOD PRESSURE DECREASED 4
106 BRONCHOPULMONARY ASPERGILLOSIS 4
107 C-REACTIVE PROTEIN INCREASED 4
108 CARDIAC FAILURE 4
109 CELLULITIS 4
110 DENTAL CARIES 4
111 DRUG ERUPTION 4
112 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4
113 ENDOCARDITIS 4
114 EXPOSURE DURING PREGNANCY 4
115 GENERALISED TONIC-CLONIC SEIZURE 4
116 HAEMATOMA 4
117 HAEMATOTOXICITY 4
118 HYPERHIDROSIS 4
119 INTERVERTEBRAL DISCITIS 4
120 PAIN IN EXTREMITY 4
121 PLACENTAL INSUFFICIENCY 4
122 PLATELET COUNT DECREASED 4
123 PNEUMONITIS 4
124 RENAL FAILURE ACUTE 4
125 RHABDOMYOLYSIS 4
126 SEIZURE 4
127 SKIN LESION 4
128 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4
129 THERAPY CESSATION 4
130 WHITE BLOOD CELL COUNT INCREASED 4
131 ACCIDENTAL EXPOSURE TO PRODUCT 3
132 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3
133 ACUTE RESPIRATORY DISTRESS SYNDROME 3
134 ACUTE RESPIRATORY FAILURE 3
135 APNOEA 3
136 ARTERIOSCLEROSIS 3
137 ASYMPTOMATIC BACTERIURIA 3
138 ATROPHY 3
139 BLISTER 3
140 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3
141 CLOSTRIDIUM DIFFICILE INFECTION 3
142 CONVULSION 3
143 CYSTIC FIBROSIS 3
144 DEAFNESS 3
145 DECREASED APPETITE 3
146 DEHYDRATION 3
147 DEVICE RELATED INFECTION 3
148 DRUG INTOLERANCE 3
149 DYSPHONIA 3
150 ENCEPHALITIS 3
151 ENTEROCOCCAL INFECTION 3
152 EOSINOPHILIC PNEUMONIA ACUTE 3
153 FACE OEDEMA 3
154 FAECES DISCOLOURED 3
155 FIBROSIS 3
156 FLUID OVERLOAD 3
157 FOETAL EXPOSURE DURING PREGNANCY 3
158 GASTROINTESTINAL HAEMORRHAGE 3
159 HEPATIC ENZYME INCREASED 3
160 INFECTION 3
161 INFLAMMATORY MARKER INCREASED 3
162 INFUSION SITE EXTRAVASATION 3
163 INTENTIONAL PRODUCT USE ISSUE 3
164 INTERSTITIAL LUNG DISEASE 3
165 IRON DEFICIENCY ANAEMIA 3
166 LINEAR IGA DISEASE 3
167 LONG QT SYNDROME 3
168 LUNG DISORDER 3
169 MALIGNANT NEOPLASM PROGRESSION 3
170 MATERNAL EXPOSURE DURING PREGNANCY 3
171 MENTAL STATUS CHANGES 3
172 MOUTH ULCERATION 3
173 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3
174 MYALGIA 3
175 MYCOBACTERIUM ABSCESSUS INFECTION 3
176 NEPHROPATHY TOXIC 3
177 NEUROTOXICITY 3
178 NEUTROPHIL COUNT DECREASED 3
179 OSTEOMYELITIS ACUTE 3
180 OSTEONECROSIS 3
181 OXYGEN SATURATION DECREASED 3
182 PNEUMOCYSTIS JIROVECII PNEUMONIA 3
183 PNEUMONIA STAPHYLOCOCCAL 3
184 PREMATURE BABY 3
185 PROCALCITONIN INCREASED 3
186 PRODUCT LABEL ISSUE 3
187 RASH GENERALISED 3
188 RASH PAPULAR 3
189 RESPIRATORY DISORDER 3
190 SKIN DISORDER 3
191 SOMNOLENCE 3
192 SUSPECTED OFF LABEL USE 3
193 TACHYCARDIA 3
194 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
195 THROAT TIGHTNESS 3
196 THROMBOCYTOPENIC PURPURA 3
197 THROMBOSIS 3
198 THROMBOTIC MICROANGIOPATHY 3
199 TOXIC SKIN ERUPTION 3
200 URINARY TRACT INFECTION 3
201 WOUND SECRETION 3
202 ABDOMINAL PAIN UPPER 2
203 ABSCESS 2
204 ADVERSE REACTION 2
205 AGEUSIA 2
206 AGITATION 2
207 ALTERED STATE OF CONSCIOUSNESS 2
208 ANURIA 2
209 AORTIC VALVE INCOMPETENCE 2
210 ARTHRALGIA 2
211 AUTOIMMUNE NEPHRITIS 2
212 BLOOD ALKALINE PHOSPHATASE INCREASED 2
213 BLOOD PRESSURE INCREASED 2
214 CARDIAC ARREST 2
215 CARDIAC DISORDER 2
216 CARDIAC VENTRICULAR THROMBOSIS 2
217 CATHETER SITE DISCHARGE 2
218 CEREBRAL HAEMORRHAGE 2
219 CEREBROVASCULAR ACCIDENT 2
220 CHEST DISCOMFORT 2
221 CHOLESTASIS 2
222 CREATININE RENAL CLEARANCE INCREASED 2
223 CYTOPENIA 2
224 DEEP VEIN THROMBOSIS 2
225 DEPRESSION 2
226 DERMATITIS ALLERGIC 2
227 DERMATITIS EXFOLIATIVE GENERALISED 2
228 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2
229 DRUG LEVEL DECREASED 2
230 DRUG-INDUCED LIVER INJURY 2
231 DYSARTHRIA 2
232 DYSPHAGIA 2
233 ESCHERICHIA BACTERAEMIA 2
234 EXTRAVASATION 2
235 FOETAL GROWTH RESTRICTION 2
236 FOLLICULAR LYMPHOMA STAGE IV 2
237 FUNGAL SKIN INFECTION 2
238 GAIT DISTURBANCE 2
239 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
240 GASTROINTESTINAL DISORDER 2
241 GINGIVAL ERYTHEMA 2
242 HAEMATURIA 2
243 HAEMODYNAMIC INSTABILITY 2
244 HAEMORRHAGE 2
245 HOSPITALISATION 2
246 HYPOPERFUSION 2
247 INSOMNIA 2
248 ISCHAEMIA 2
249 LEUKOCYTOSIS 2
250 MENINGITIS ASEPTIC 2
251 MUSCULOSKELETAL PAIN 2
252 MYOCLONUS 2
253 NO ADVERSE EVENT 2
254 OCULAR HYPERAEMIA 2
255 ORAL DISORDER 2
256 PANCREATITIS 2
257 PERIPHERAL SWELLING 2
258 PHOTOPHOBIA 2
259 PLACENTAL DISORDER 2
260 PRE-ECLAMPSIA 2
261 PRODUCT DOSE OMISSION ISSUE 2
262 PRODUCT QUALITY ISSUE 2
263 PRODUCTIVE COUGH 2
264 PROTHROMBIN TIME PROLONGED 2
265 PSEUDOMEMBRANOUS COLITIS 2
266 PUBIS FRACTURE 2
267 PURPURA 2
268 RASH MACULAR 2
269 RENAL FAILURE NEONATAL 2
270 RENAL INJURY 2
271 RENAL ISCHAEMIA 2
272 RESPIRATORY RATE INCREASED 2
273 SJS-TEN OVERLAP 2
274 SKIN ATROPHY 2
275 SKIN DISCOLOURATION 2
276 SKIN EROSION 2
277 SKIN INFECTION 2
278 SKIN STRIAE 2
279 SKIN WRINKLING 2
280 SPINAL STENOSIS 2
281 STAPHYLOCOCCAL SEPSIS 2
282 SWELLING FACE 2
283 TONGUE ERYTHEMA 2
284 TREATMENT NONCOMPLIANCE 2
285 TYPE IV HYPERSENSITIVITY REACTION 2
286 WEIGHT INCREASED 2
287 ABDOMINAL DISTENSION 1
288 ABDOMINAL HERNIA 1
289 ABDOMINAL SEPSIS 1
290 ACINETOBACTER INFECTION 1
291 ACUTE HEPATIC FAILURE 1
292 ACUTE LUNG INJURY 1
293 ACUTE MYOCARDIAL INFARCTION 1
294 ADMINISTRATION SITE DISCOMFORT 1
295 ADMINISTRATION SITE OEDEMA 1
296 ADVERSE DRUG REACTION 1
297 ALOPECIA 1
298 ANKLE FRACTURE 1
299 ANTI-PLATELET FACTOR 4 ANTIBODY POSITIVE 1
300 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1
301 ANTINUCLEAR ANTIBODY POSITIVE 1
302 ANXIETY 1
303 APPETITE DISORDER 1
304 AREFLEXIA 1
305 ARTHRITIS BACTERIAL 1
306 ARTHROPOD BITE 1
307 ASTHMA 1
308 AZOTAEMIA 1
309 BACILLUS INFECTION 1
310 BACTERIAL DISEASE CARRIER 1
311 BACTERIAL INFECTION 1
312 BACTERIAL SEPSIS 1
313 BALANCE DISORDER 1
314 BLINDNESS 1
315 BLOOD COUNT ABNORMAL 1
316 BLOOD CREATININE ABNORMAL 1
317 BLOOD GLUCOSE FLUCTUATION 1
318 BLOOD GLUCOSE INCREASED 1
319 BLOOD IRON DECREASED 1
320 BLOOD MAGNESIUM DECREASED 1
321 BLOOD UREA INCREASED 1
322 BODY TEMPERATURE INCREASED 1
323 BONE MARROW FAILURE 1
324 BONE MARROW TOXICITY 1
325 BRAIN FOG 1
326 BREATH SOUNDS ABNORMAL 1
327 BRONCHIECTASIS 1
328 BRONCHOSPASM 1
329 BURNING SENSATION 1
330 CANDIDA TEST POSITIVE 1
331 CARBOHYDRATE ANTIGEN 125 INCREASED 1
332 CARDIAC DYSFUNCTION 1
333 CARDIAC FAILURE CONGESTIVE 1
334 CARDIOPULMONARY FAILURE 1
335 CARDIOVASCULAR DISORDER 1
336 CATHETER SITE INFLAMMATION 1
337 CEREBRAL ISCHAEMIA 1
338 CHOLELITHIASIS 1
339 CHRONIC KIDNEY DISEASE 1
340 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1
341 CLOSTRIDIUM DIFFICILE COLITIS 1
342 CLOSTRIDIUM TEST POSITIVE 1
343 COAGULOPATHY 1
344 COMPUTERISED TOMOGRAM ABNORMAL 1
345 CONSTIPATION 1
346 CULTURE WOUND POSITIVE 1
347 CYSTITIS 1
348 DEBRIDEMENT 1
349 DECUBITUS ULCER 1
350 DELIRIUM 1
351 DERMATITIS 1
352 DERMATITIS BULLOUS 1
353 DERMATITIS EXFOLIATIVE 1
354 DEVICE DISLOCATION 1
355 DIABETES INSIPIDUS 1
356 DIABETIC COMA 1
357 DIABETIC KETOACIDOSIS 1
358 DIABETIC NEUROPATHY 1
359 DIPLOPIA 1
360 DISCOMFORT 1
361 DISCOURAGEMENT 1
362 DISSEMINATED INTRAVASCULAR COAGULATION 1
363 DRUG LEVEL BELOW THERAPEUTIC 1
364 DRUG LEVEL INCREASED 1
365 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
366 DRUG SPECIFIC ANTIBODY 1
367 DUODENAL ULCER HAEMORRHAGE 1
368 DYSGEUSIA 1
369 DYSPEPSIA 1
370 DYSPHEMIA 1
371 EAR INFECTION 1
372 EJECTION FRACTION DECREASED 1
373 ELECTROLYTE IMBALANCE 1
374 END STAGE RENAL DISEASE 1
375 ENDOCARDITIS STAPHYLOCOCCAL 1
376 ENTEROCOCCAL BACTERAEMIA 1
377 EOSINOPHILS URINE PRESENT 1
378 EPIDIDYMITIS 1
379 EPISTAXIS 1
380 ERYTHEMA MULTIFORME 1
381 EXFOLIATIVE RASH 1
382 EXPOSURE VIA INGESTION 1
383 EXTRADURAL ABSCESS 1
384 EYE DISORDER 1
385 EYE SWELLING 1
386 FALSE POSITIVE INVESTIGATION RESULT 1
387 FEELING ABNORMAL 1
388 FINE MOTOR DELAY 1
389 FLUID RETENTION 1
390 FLUSHING 1
391 FOOT AMPUTATION 1
392 FULL BLOOD COUNT DECREASED 1
393 FUNGAL INFECTION 1
394 GASTRIC ULCER 1
395 GASTRITIS 1
396 GASTROINTESTINAL SOUNDS ABNORMAL 1
397 GASTROINTESTINAL TRACT ADENOMA 1
398 GASTROOESOPHAGEAL REFLUX DISEASE 1
399 GINGIVITIS 1
400 GLOMERULAR FILTRATION RATE ABNORMAL 1
401 GLOMERULONEPHRITIS 1
402 GLYCOSYLATED HAEMOGLOBIN INCREASED 1
403 GRANULOCYTOSIS 1
404 GROWTH RETARDATION 1
405 HAEMOLYTIC URAEMIC SYNDROME 1
406 HAEMORRHAGE INTRACRANIAL 1
407 HEARING IMPAIRED 1
408 HEART RATE DECREASED 1
409 HEART RATE INCREASED 1
410 HEART RATE IRREGULAR 1
411 HEMIPLEGIA 1
412 HEPARIN-INDUCED THROMBOCYTOPENIA 1
413 HEPATITIS 1
414 HEPATITIS ACUTE 1
415 HEPATOCELLULAR INJURY 1
416 HEPATOMEGALY 1
417 HILAR LYMPHADENOPATHY 1
418 HOSPICE CARE 1
419 HYPERAEMIA 1
420 HYPERBILIRUBINAEMIA 1
421 HYPERCALCAEMIA 1
422 HYPERPARATHYROIDISM SECONDARY 1
423 HYPERSOMNIA 1
424 HYPERTENSIVE CRISIS 1
425 HYPERVOLAEMIA 1
426 HYPOAESTHESIA 1
427 HYPOAESTHESIA ORAL 1
428 HYPOALBUMINAEMIA 1
429 HYPOCALCAEMIA 1
430 HYPOGLYCAEMIA 1
431 HYPONATRAEMIA 1
432 HYPOXIA 1
433 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1
434 ILLNESS 1
435 IMMUNE THROMBOCYTOPENIA 1
436 IMMUNE-MEDIATED ADVERSE REACTION 1
437 INCISION SITE INFLAMMATION 1
438 INCORRECT DOSE ADMINISTERED 1
439 INCORRECT DRUG ADMINISTRATION DURATION 1
440 INCORRECT DRUG ADMINISTRATION RATE 1
441 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
442 INCORRECT STORAGE OF DRUG 1
443 INFECTIOUS COLITIS 1
444 INFUSION RELATED REACTION 1
445 INJECTION SITE PAIN 1
446 INTENTIONAL PRODUCT MISUSE 1
447 INTRAOCULAR PRESSURE INCREASED 1
448 INTRAVASCULAR HAEMOLYSIS 1
449 JOINT DISLOCATION 1
450 KIDNEY TRANSPLANT REJECTION 1
451 KLEBSIELLA BACTERAEMIA 1
452 KLEBSIELLA INFECTION 1
453 LATENT SYPHILIS 1
454 LIGAMENT SPRAIN 1
455 LIMB INJURY 1
456 LIP OEDEMA 1
457 LIP PRURITUS 1
458 LIVER FUNCTION TEST ABNORMAL 1
459 LIVER FUNCTION TEST INCREASED 1
460 LIVER INJURY 1
461 LOCALISED INFECTION 1
462 LOWER GASTROINTESTINAL HAEMORRHAGE 1
463 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III 1
464 LUNG INFECTION 1
465 LUNG NEOPLASM MALIGNANT 1
466 MALABSORPTION 1
467 MALNUTRITION 1
468 MAST CELL ACTIVATION SYNDROME 1
469 MASTICATION DISORDER 1
470 METABOLIC ACIDOSIS 1
471 METABOLIC ENCEPHALOPATHY 1
472 MICTURITION FREQUENCY DECREASED 1
473 MITRAL VALVE INCOMPETENCE 1
474 MOBILITY DECREASED 1
475 MUCOSAL INFLAMMATION 1
476 MULTI-ORGAN FAILURE 1
477 MULTIPLE SCLEROSIS RELAPSE 1
478 MUSCLE SPASMS 1
479 MUSCULAR WEAKNESS 1
480 MUSCULOSKELETAL DISCOMFORT 1
481 MYCOBACTERIAL INFECTION 1
482 MYCOPLASMA INFECTION 1
483 MYDRIASIS 1
484 MYELODYSPLASTIC SYNDROME 1
485 MYELOSUPPRESSION 1
486 MYOCARDIAL INFARCTION 1
487 NASOPHARYNGITIS 1
488 NECK PAIN 1
489 NECROTISING FASCIITIS 1
490 NEOPLASM MALIGNANT 1
491 NEOPLASM PROGRESSION 1
492 NEPHROGENIC ANAEMIA 1
493 NEPHROPATHY 1
494 NEPHROTIC SYNDROME 1
495 NERVOUSNESS 1
496 NEUROLOGICAL DECOMPENSATION 1
497 NEUROPATHY PERIPHERAL 1
498 NO THERAPEUTIC RESPONSE 1
499 NOCARDIOSIS 1
500 NOCTURIA 1
501 NORMAL NEWBORN 1
502 OCCULT BLOOD POSITIVE 1
503 ORAL CANDIDIASIS 1
504 ORAL DISCOMFORT 1
505 ORAL MUCOSA EROSION 1
506 OROPHARYNGEAL DISCOMFORT 1
507 OROPHARYNGEAL PAIN 1
508 OXYGEN CONSUMPTION INCREASED 1
509 PALLOR 1
510 PALPITATIONS 1
511 PANCREATIC CYST 1
512 PANCREATIC HAEMORRHAGE 1
513 PARAESTHESIA 1
514 PELVIC FLUID COLLECTION 1
515 PERICARDITIS INFECTIVE 1
516 PERIPHERAL ARTERY THROMBOSIS 1
517 PERITONITIS BACTERIAL 1
518 PETECHIAE 1
519 PHARYNGEAL OEDEMA 1
520 PHARYNGEAL SWELLING 1
521 PHLEBITIS 1
522 PLEURAL EFFUSION 1
523 PNEUMONIA BACTERIAL 1
524 PNEUMONIA CYTOMEGALOVIRAL 1
525 PNEUMONIA VIRAL 1
526 PNEUMOTHORAX 1
527 PNEUMOTHORAX SPONTANEOUS 1
528 POOR QUALITY PRODUCT ADMINISTERED 1
529 PORTAL VEIN DILATATION 1
530 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1
531 POSTOPERATIVE WOUND COMPLICATION 1
532 PREGNANCY 1
533 PRESCRIBED OVERDOSE 1
534 PRESYNCOPE 1
535 PRODUCT CLOSURE ISSUE 1
536 PRODUCT COLOUR ISSUE 1
537 PRODUCT CONTAMINATION PHYSICAL 1
538 PRODUCT DOSE OMISSION 1
539 PRODUCT ODOUR ABNORMAL 1
540 PRODUCT PACKAGING ISSUE 1
541 PRODUCT RECONSTITUTION QUALITY ISSUE 1
542 PRODUCT SOLUBILITY ABNORMAL 1
543 PRODUCT TEMPERATURE EXCURSION ISSUE 1
544 PROTEINURIA 1
545 PSEUDOMONAS TEST POSITIVE 1
546 PSOAS ABSCESS 1
547 PULMONARY ALVEOLAR HAEMORRHAGE 1
548 PULMONARY EMBOLISM 1
549 PULMONARY FUNCTION TEST ABNORMAL 1
550 PULMONARY HAEMORRHAGE 1
551 PULMONARY OEDEMA 1
552 PURULENT DISCHARGE 1
553 PYELONEPHRITIS 1
554 RASH MORBILLIFORM 1
555 REACTION TO EXCIPIENT 1
556 RECTAL HAEMORRHAGE 1
557 RENAL ABSCESS 1
558 RENAL DISORDER 1
559 RENAL FAILURE CHRONIC 1
560 RENAL INFARCT 1
561 RENAL TUBULAR NECROSIS 1
562 RESPIRATORY DISTRESS 1
563 RESPIRATORY TRACT INFECTION 1
564 SEBORRHOEIC DERMATITIS 1
565 SEPTIC PULMONARY EMBOLISM 1
566 SHOCK 1
567 SINUS TACHYCARDIA 1
568 SKIN ABRASION 1
569 SKIN EXFOLIATION 1
570 SKIN INJURY 1
571 SKIN PLAQUE 1
572 SKIN TEST POSITIVE 1
573 SOFT TISSUE INFECTION 1
574 SPEECH DISORDER 1
575 SPINAL COMPRESSION FRACTURE 1
576 SPINAL EPIDURAL HAEMATOMA 1
577 SPLENIC INFARCTION 1
578 STAPHYLOCOCCUS TEST POSITIVE 1
579 STASIS DERMATITIS 1
580 STRESS CARDIOMYOPATHY 1
581 STRIDOR 1
582 SUBCUTANEOUS ABSCESS 1
583 SUPERFICIAL VEIN THROMBOSIS 1
584 SUPRAVENTRICULAR EXTRASYSTOLES 1
585 SUPRAVENTRICULAR TACHYCARDIA 1
586 SWELLING 1
587 SWOLLEN TONGUE 1
588 SYNCOPE 1
589 TACHYPNOEA 1
590 TASTE DISORDER 1
591 THERAPEUTIC PRODUCT EFFECT DECREASED 1
592 THERAPY CHANGE 1
593 THERAPY INTERRUPTED 1
594 THROAT IRRITATION 1
595 THROAT LESION 1
596 THROMBOANGIITIS OBLITERANS 1
597 THROMBOSIS IN DEVICE 1
598 THYROIDITIS 1
599 TONGUE DISORDER 1
600 TONGUE EXFOLIATION 1
601 TONGUE PRURITUS 1
602 TOOTH ABSCESS 1
603 TOOTH INFECTION 1
604 TOOTHACHE 1
605 TOXICITY TO VARIOUS AGENTS 1
606 TRANSFUSION-RELATED ACUTE LUNG INJURY 1
607 TRANSPLANT REJECTION 1
608 TROPONIN INCREASED 1
609 TULARAEMIA 1
610 UNRESPONSIVE TO STIMULI 1
611 URINARY TRACT OBSTRUCTION 1
612 UTERINE LEIOMYOMA 1
613 VACCINATION SITE PAIN 1
614 VASCULAR DEVICE INFECTION 1
615 VASCULAR INJURY 1
616 VASCULAR PURPURA 1
617 VASCULITIS 1
618 VENTRICULAR EXTRASYSTOLES 1
619 VESTIBULAR MIGRAINE 1
620 VIRAL INFECTION 1
621 VISION BLURRED 1
622 VISUAL ACUITY REDUCED 1
623 VULVOVAGINAL RASH 1
624 WALKING AID USER 1
625 WHEEZING 1
626 WHITE BLOOD CELL DISORDER 1
627 WITHDRAWAL SYNDROME 1
628 WOUND COMPLICATION 1
629 WOUND HAEMORRHAGE 1
630 WOUND INFECTION 1
631 WOUND INFECTION BACTERIAL 1